US Pharma MarketingThe post Clinical trial statistics gets an AI-era overhaul appeared first on Clinical Trials Arena.
Clinical trial statistics gets an AI-era overhaul
For decades, statistical analysis has remained one of clinical research's most manual processes. As AI reshapes drug development, CROs and sponsors are asking whether biostatistics could be the next major efficiency breakthrough. For decades, statistical analysis has remained one of clinical research's most manual processes. As AI reshapes drug development, CROs and sponsors are asking whether biostatistics could be the next major efficiency breakthrough. Clinical research is rethinking one of its most entrenched workflows, using AI and automation to transform how trial data is analysed and reported. Image credit: Shutterstock/ArtemisDiana For much of the pharmaceutical industry’s discussion around artificial intelligence…
For decades, statistical analysis has remained one of clinical research's most manual processes. As AI reshapes drug development, CROs and sponsors are asking whether biostatistics could be the next major efficiency breakthrough.
Source: Clinical Trials Arena